THE PROBLEM OF OBESITY AND OVERWEIGHT IN THE RUSSIAN FEDERATION AND ITS PHARMACOECONOMIC ASSESSMENT

Abstract

Background: Due to high prevalence of obesity that has turned into enormous economic and social burden, studies aimed at assessment of damages caused by this medico-social problem are seen as very important in the last years. Aim: To assess economic burden of obesity in the Russian Federation taking as an example three main socially significant medical conditions: acute cerebrovascular accident (stroke), acute myocardial infarction (AMI) and type 2 diabetes mellitus (T2DM).Materials and methods: We analyzed available evidence on assessment of costs of management and treatment of obese patients and its relation to the disorders selected. To measure costs of obesity for the state budget, we used clinical and economic analysis “cost of illness” with consideration of risks of stroke, AMI and T2DM in the population. Taking into account specific features of cost assessment and based on publically available data, we developed separate models to calculate cost of illness for each selected disease type.Results: Obesity-related expenses incurred by the state for treatment and management of patients amounted to 10.2 billion rubles for stroke, 7.6 billion rubles for AMI and 346.3 billion rubles for T2DM.Conclusion: Оbesity is a serious problem causing significant economic and social losses that are increasing.

Keywords

• obesity, economic burden, direct costs, cerebrovascular accident, stroke, acute myocardial infarction, type 2 diabetes mellitus, pharmacoeconomy